Markets.News

QURE  UNIQURE NV

+ add to watchlist

$17.21

uniqure is delivering on the promise of gene therapy - single treatments with potentially curative results. we are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.

Mkt Cap: $1.07B

52 Week High: $71.50

P/E: -1.00

52 Week Low: $7.76

Dividend: $0.00

Shares Outstanding: 62.53M

This news is delayed by 15 minutes, sign up now to get live news & full features.